tm logo

Monitor this mark

View On USPTO

HETLIOZ
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 17 Jun 2024

Last Applicant/ Owned by

Vanda Pharmaceuticals Inc.

2200 Pennsylvania Ave. NW

Washington

DC

20037

Serial Number

97791877 filed on 13th Feb 2023

Registration Number

N/A

Correspondent Address

Jayme M. Torelli

Jayme M. Torelli HOFFMAN WARNICK LLC

4TH FLOOR

ALBANY, NY 12207

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

HETLIOZ

Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of autism spectrum disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of autism spectrum disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97791877

Mark Type

No Service/Collective Mark

Attorney Docket Number

No VAND-0098US3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Jun 2024SOU EXTENSION 1 GRANTED
17th Jun 2024SOU EXTENSION 1 FILED
17th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Jun 2024SOU TEAS EXTENSION RECEIVED
13th Feb 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19th Dec 2023PUBLISHED FOR OPPOSITION
19th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16th Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
13th Nov 2023ASSIGNED TO EXAMINER